Skip to Main Content

Paper Details

Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.
J Clin Oncol
92
2018
CCSS, Childhood Cancer, Children, Ischemic Heart Disease, Ischemic heart disease, Participants, Patients, Stroke, childhood cancer, heart disease, ischemic heart disease, participants, stroke
Author NameAffiliation
Melissa M HudsonEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Marilyn StovallEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Marilyn StovallEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Rita E WeathersEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Rita E WeathersEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Leslie L RobisonEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Leslie L RobisonEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Gregory T ArmstrongEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
Gregory T ArmstrongEric J. Chow Fred Hutchinson Cancer Research Center, University of Washington, University of Alberta, St Jude Children's Research Hospital Daniel A. Mulrooney, University of Tennessee, Emma Children's Hospital, Academic Medical Center Irma W.E.M. van Dijk, Academic Medical Center Flora E. van Leeuwen, The Netherlands Cancer Institute, Princess Maxima Center for Pediatric Oncology, Emory University, Duke University Medical Center, Memorial Sloan-Kettering Cancer Center, The University of Texas MD Anderson Cancer Center
  • 1 - 9

Datasets